Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Joshua K. Sabari"'
Autor:
Matthew Siskin, Joshua K. Sabari
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 7, Iss , Pp 100171- (2022)
An 83-year-old woman presents with two synchronous primary lung adenocarcinomas each harboring unique EGFR mutations, one classical and the other rare. She was treated with adjuvant Osimertinib following surgical lobectomy and remains well 44 months
Externí odkaz:
https://doaj.org/article/c57631da89ea4adcafa8c76d23844b83
Autor:
Annie Wang, Stephanie H. Chang, Eric J. Kim, Jamie L. Bessich, Joshua K. Sabari, Benjamin Cooper, Travis C. Geraci, Robert J. Cerfolio
Publikováno v:
Frontiers in Surgery, Vol 8 (2021)
Management of patients with lung cancer continues to be challenging during the COVID-19 pandemic, due to the increased risk of complications in this subset of patients. During the COVID-19 surge in New York City, New York University Langone Health ad
Externí odkaz:
https://doaj.org/article/04d7d7c0a0674428ba0b5b0307f7749d
Autor:
Madhuri Martin, Joshua K. Sabari, Gulisa Turashvili, Darragh F. Halpenny, Hira Rizvi, Natalie Shapnik, Vicky Makker
Publikováno v:
Gynecologic Oncology Reports, Vol 24, Iss , Pp 94-98 (2018)
Introduction: Multiple primary tumors (MPTs) are defined as two or more separate synchronous or metachronous neoplasms occurring in different sites in the same individual. These tumors differ in histology, as well as primary sites from which they ari
Externí odkaz:
https://doaj.org/article/6e70fb5073294f24a54a2fa8f20d3a78
Autor:
Keunchil Park, Joshua K. Sabari, Eric B. Haura, Catherine A. Shu, Alexander Spira, Ravi Salgia, Karen L. Reckamp, Rachel E. Sanborn, Ramaswamy Govindan, Joshua M. Bauml, Joshua C. Curtin, John Xie, Amy Roshak, Patricia Lorenzini, Dawn Millington, Meena Thayu, Roland E. Knoblauch, Byoung Chul Cho
Publikováno v:
Lung Cancer. 178:166-171
Autor:
Andre L. Moreira, Joshua K. Sabari
Publikováno v:
Journal of Thoracic Oncology. 18:396-398
Autor:
Sai-Hong Ignatius Ou, Pasi A. Jänne, Ticiana A. Leal, Igor I. Rybkin, Joshua K. Sabari, Minal A. Barve, Lyudmila Bazhenova, Melissa L. Johnson, Karen L. Velastegui, Cornelius Cilliers, James G. Christensen, Xiaohong Yan, Richard C. Chao, Kyriakos P. Papadopoulos
Publikováno v:
Journal of Clinical Oncology. 40:2530-2538
PURPOSE Adagrasib (MRTX849) is an oral, highly selective, small-molecule, covalent inhibitor of KRASG12C. We report results from a phase I/IB study of adagrasib in non–small-cell lung cancer, colorectal cancer, and other solid tumors harboring the
Autor:
Pasi A. Jänne, Gregory J. Riely, Shirish M. Gadgeel, Rebecca S. Heist, Sai-Hong I. Ou, Jose M. Pacheco, Melissa L. Johnson, Joshua K. Sabari, Konstantinos Leventakos, Edwin Yau, Lyudmila Bazhenova, Marcelo V. Negrao, Nathan A. Pennell, Jun Zhang, Kenna Anderes, Hirak Der-Torossian, Thian Kheoh, Karen Velastegui, Xiaohong Yan, James G. Christensen, Richard C. Chao, Alexander I. Spira
Publikováno v:
New England Journal of Medicine. 387:120-131
Autor:
Tanios S. Bekaii-Saab, Rona Yaeger, Alexander I. Spira, Meredith S. Pelster, Joshua K. Sabari, Navid Hafez, Minal Barve, Karen Velastegui, Xiaohong Yan, Aditya Shetty, Hirak Der-Torossian, Shubham Pant
Publikováno v:
Journal of Clinical Oncology.
PURPOSE Adagrasib, a KRASG12C inhibitor, has demonstrated clinical activity in patients with KRASG12C-mutated non-small cell lung cancer (NSCLC) and colorectal cancer (CRC). KRASG12C mutations occur rarely in other solid tumor types. We report evalua
Autor:
Hiroaki Wakimoto, Priscilla K. Brastianos, Sylvia C. Kurz, James G. Christensen, Peter Olson, Jill Hallin, Aaron C. Burns, Edwin Nieblas-Bedolla, Anant P. Rajan, Justin F. Gainor, Subba R. Digumarthy, Anita Giobbie-Hurder, Naema Nayyar, Mohini Singh, Rebecca S. Heist, Matthew R. Strickland, Kazuhide Shimizu, Vamsidhar Velcheti, Joshua K. Sabari
Supplementary Figure from Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non–Small Cell Lung Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11df31c80f052bc97f17bbf94e0f818e
https://doi.org/10.1158/1078-0432.22488066
https://doi.org/10.1158/1078-0432.22488066
Autor:
Natasha Rekhtman, Alexander Drilon, Marc Ladanyi, William D. Travis, Maria E. Arcila, Alison M. Schram, Bob T. Li, Laetitia Borsu, Khedoudja Nafa, Ryma Benayed, Joshua K. Sabari, Sarah Teed, Valerie W. Rusch, Prasad S. Adusumilli, Kyuichi Kadota, Patrice Desmeules, Joseph Montecalvo, Sharon Amir, Helen H. Won, Vasilisa A. Rudneva, Fanli Meng, Brian R. Houck-Loomis, David Brown, Christina Falcon, Michael Offin, Jason C. Chang
Supplemental Methods 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c3f8118ca794b752039fbf3a74ead09
https://doi.org/10.1158/1078-0432.22480620.v1
https://doi.org/10.1158/1078-0432.22480620.v1